Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

CV Health Scores & Increased Risk of CVD and Death

J Am Heart Assoc; ePub 2018 May 17; Enserro, et al

Over the past 20 years, the decreased presence of ideal cardiovascular health (CVH) scores has resulted in increasing odds of subclinical disease and risk of cardiovascular disease (CVD) and death, a recent study found. The study included 3,460 participants (mean age 55.4 years, CVH score ranged 0-14) attending ≥1 of 4 consecutive exams of the Framingham Heart Study. Researchers created 4 groups describing changes in CVH score between examination cycles 5 and 8, using first and last exams attended and related them to subclinical CVD cross-sectionally, and incident CVD and death. They found:

  • Fewer people have ideal CVH scores over the past 20 years due to decreases in those with ideal status of body mass index (BMI), blood glucose, and serum cholesterol levels.
  • The odds of subclinical disease and risk of CVD and death were higher for all compared with the high-high group.
  • These findings emphasize the importance of maintaining ideal CVH over the life course.

Citation:

Enserro DM, Vasan RS, Xanthakis V. Twenty-year trends in the American Heart Association cardiovascular health score and impact on subclinical and clinical cardiovascular disease: The Framingham Offspring Study. [Published online ahead of print May 17, 2018]. J Am Heart Assoc. doi:10.1161/JAHA.118.008741.

This Week's Must Reads

Tdap Immunization & Neonatal Pertussis Antibodies, JAMA; 2018 Oct 9; Healy, Rench, et al

Influenza Vaccine Effectiveness During Pregnancy, Clin Infect Dis; ePub 2018 Oct 11; Thompson, et al

Vaccination Coverage & Exemption Rates in Children, MMWR; 2018 Oct 12; Mellerson, Maxwell, et al

Severe Pertussis Infections in All Age Groups, Clin Infect Dis; ePub 2018 Oct 15; Mbayei, et al

Influenza Vaccine Type Preference Among Parents, Vaccine; ePub 2018 Oct 16; Santibanez, et al

Must Reads in Cardiology

Treating Low-Risk Patients with Mild Hypertension, JAMA Intern Med; ePub 2018 Oct 29; Sheppard, et al

Concomitant DOAC-Antiplatelet Use & Bleeding Risk, Am J Med; ePub 2018 Oct 25; Douros, et al

Omega 3 Polyunsaturated Fatty Acids & Healthy Aging, BMJ; ePub 2018 Oct 17; Lai, Otto, et al

Kidney Damage Biomarkers & Incident CKD in BP Reduction, Ann Intern Med; ePub 2018 Oct 23; Zhang, et al

Excess Hypertension Risk in Black Adults, JAMA; 2018 Oct 8; Howard, Cushman, et al